Soon-Siong Teo

发表

A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Mario Cazzola, Robert Kralovics, M. Cazzola, 2005, The New England journal of medicine.

Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice

P. Couttet, D. Schübeler, Tim C. Roloff, 2011, PloS one.

Mapping the epigenome--impact for toxicology.

F. Pognan, Soon-Siong Teo, J. Moggs, 2009, EXS.

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

M. Olschewski, Soon-Siong Teo, R. Skoda, 2008, Haematologica.

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Soon-Siong Teo, A. Tichelli, R. Skoda, 2006, Blood.

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

R. Kralovics, A. Buser, Soon-Siong Teo, 2006, Blood.

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders.

R. Kralovics, A. Buser, Soon-Siong Teo, 2003, Blood.

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

M. Cazzola, R. Kralovics, F. Passamonti, 2005, Blood.

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V 617 F mutation of Jak 2

M. Cazzola, R. Kralovics, F. Passamonti, 2005 .